CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

CVS Health (NYSE:CVS), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 ...

With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...

of customers agree our service is more convenient than ordering via a GP The new NHS Electronic Prescription Service (EPS) means all your repeat prescriptions can now be arranged and delivered free ...

CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health ...

Prescriptions filled increased by 3.3%, and Same-store prescription volume increased by 5.9% in the quarter. Guidance: CVS Health forecasts fiscal year 2025 adjusted EPS of $5.75-$6.00 versus ...